Table 1 Demographic characteristics
N (%) | One dose: N = 35 (50%) | No dose: N = 35 (50%) |
|---|---|---|
Gender | ||
Male | 21 (60%) | 10 (28%) |
Female | 14 (40%) | 23 (66%) |
Prefer not to say | 0 | 2 (6%) |
Age | ||
18–24 | 0 | 12 (34%) |
25–29 | 0 | 22 (63%) |
30–34 | 15 (43%) | 0 |
35–39 | 6 (17%) | 0 |
40–44 | 8 (23%) | 0 |
45–49 | 6 (17%) | 0 |
Prefer not to say | 0 | 1 (3%) |
Education | ||
Employed full time | 20 (57%) | 13 (37) |
Employed part time | 4 (11%) | 9 (26%) |
Full time education | 0 | 2 (6%) |
Unemployed | 4 (11%) | 3 (9%) |
Home maker | 2 (6%) | 1 (3%) |
Self employed | 3 (9%) | 0 |
Unable to work | 1 (3%) | 0 |
Prefer not to say | 1 (3%) | 4 (12%) |
Education | ||
Still in full time education | 0 | 2 (6%) |
Before finishing school | 0 | 0 |
After finishing school | 6 (17%) | 7 (20%) |
After finishing college | 10 (29%) | 11 (31%) |
After finishing university | 17 (49%) | 9 (26%) |
After postgraduate studies | 1 (3%) | 2 (6%) |
Prefer not to say | 1 (3%) | 4 (12%) |
Ethnicity | ||
White | 14 (40%) | 18 (51%) |
Mixed/multiple ethnic groups | 0 | 2 (6%) |
Asian/Asian British | 5 (14%) | 5 (14%) |
Black/African/Caribbean/Black British | 11 (31%) | 7 (20%) |
Other ethnic group | 5 (14%) | 1 (3%) |
Prefer not to say | 0 | 2 (6%) |
Vaccine | ||
Moderna | 7 (20%) | NA |
Pfizer | 21 (60%) | NA |
AstraZeneca | 7 (20%) | NA |